Yu, Shang-Fan
Genentech
4 papers on CoChatORCID 0009-0002-2625-663X
Most cited papers
- Verified
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity
Pillow, T. H., Adhikari, P., Blake, R. A., Chen, J., Del Rosario, G., Deshmukh, G., Figueroa, I., Gascoigne, K. E., Kamath, A. V., Kaufman, S., et al. (2020) · ChemMedChem
Protein Degradation and InhibitorsChemical Synthesis and Analysis
Cited by 216
- Verified
Targeting LGR5 + cells with an antibody-drug conjugate for the treatment of colon cancer
Junttila, M. R., Mao, W., Wang, X., Wang, B.-E., Pham, T., Flygare, J., Yu, S.-F., Yee, S., Goldenberg, D., Fields, C., et al. (2015) · Science Translational Medicine
Cancer Cells and MetastasisColorectal Cancer Treatments and Studies
Cited by 182
- Verified
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy
Dragovich, P. S., Pillow, T. H., Blake, R. A., Sadowsky, J. D., Adaligil, E., Adhikari, P., Chen, J., Corr, N., dela Cruz-Chuh, J., Del Rosario, G., et al. (2021) · Journal of Medicinal Chemistry
Protein Degradation and InhibitorsMonoclonal and Polyclonal Antibodies Research
Cited by 174
- Verified
T cell-dependent bispecific therapy enhances innate immune activation and antibody-mediated killing
Besla, R., Penuel, E., Del Rosario, G., Cosino, E., Myrta, S., Dillon, M., Lazar, G. A., Nickles, D., Spiess, C., Yu, S.-F., et al. (2024) · Cancer Immunology Research
Immune Cell Function and InteractionMonoclonal and Polyclonal Antibodies Research
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free